AAPL342.56-6.65 (-1.90%) ▼|ABBV286.20+2.66 (+0.94%) ▲|ABT103.00-0.87 (-0.84%) ▼|ACN221.17+2.59 (+1.18%) ▲|ADBE217.71-3.97 (-1.79%) ▼|AMAT302.63-36.30 (-10.71%) ▼|AMD424.39-64.80 (-13.25%) ▼|AMGN435.64-0.66 (-0.15%) ▼|AMT184.21+3.06 (+1.69%) ▲|AMZN246.82-10.55 (-4.10%) ▼|AVGO304.41-42.24 (-12.19%) ▼|AXP301.70-9.41 (-3.02%) ▼|BA155.89-4.62 (-2.88%) ▼|BAC47.04-1.53 (-3.15%) ▼|BKNG144.91-2.41 (-1.64%) ▼|BLK1,101.72-34.09 (-3.00%) ▼|BMY58.80+0.46 (+0.79%) ▲|BNY141.24-3.59 (-2.48%) ▼|BRK-B570.00-2.04 (-0.36%) ▼|C110.62-4.66 (-4.04%) ▼|CAT510.45-26.92 (-5.01%) ▼|CL98.71+1.83 (+1.89%) ▲|CMCSA24.90+0.04 (+0.16%) ▲|COF178.66-3.10 (-1.71%) ▼|COP136.12+1.13 (+0.84%) ▲|COST1,102.15+8.32 (+0.76%) ▲|CRM180.62-2.69 (-1.47%) ▼|CSCO90.64-4.06 (-4.29%) ▼|CVS80.84+0.80 (+1.00%) ▲|CVX208.37+1.87 (+0.91%) ▲|DE609.25-15.64 (-2.50%) ▼|DHR220.36-7.20 (-3.16%) ▼|DIS117.98-2.27 (-1.89%) ▼|DUK129.78+0.92 (+0.71%) ▲|EMR150.93-6.67 (-4.23%) ▼|FDX303.99-10.65 (-3.38%) ▼|GD341.50-5.84 (-1.68%) ▼|GE309.62-9.26 (-2.90%) ▼|GEV699.33-56.95 (-7.53%) ▼|GILD166.43-0.10 (-0.06%) ▼|GM78.71-3.04 (-3.72%) ▼|GOOG264.00-7.02 (-2.59%) ▼|GOOGL265.29-7.37 (-2.70%) ▼|GS790.69-56.84 (-6.71%) ▼|HD339.04+2.36 (+0.70%) ▲|HON212.64-5.20 (-2.39%) ▼|IBM224.44+0.56 (+0.25%) ▲|INTC51.28-4.44 (-7.97%) ▼|INTU270.44-39.58 (-12.77%) ▼|ISRG399.05-8.19 (-2.01%) ▼|JNJ270.47+3.33 (+1.25%) ▲|JPM310.53-9.69 (-3.03%) ▼|KO96.99+0.90 (+0.94%) ▲|LIN502.83-7.38 (-1.45%) ▼|LLY1,347.11-4.01 (-0.30%) ▼|LMT565.50-6.35 (-1.11%) ▼|LOW220.84+1.70 (+0.78%) ▲|LRCX183.27-20.41 (-10.02%) ▼|MA625.59-0.91 (-0.15%) ▼|MCD273.24+0.89 (+0.33%) ▲|MDLZ66.28+0.59 (+0.90%) ▲|MDT99.94-0.67 (-0.67%) ▼|META560.84-35.38 (-5.93%) ▼|MMM177.99-0.48 (-0.27%) ▼|MO74.87+0.19 (+0.25%) ▲|MRK133.72+0.91 (+0.69%) ▲|MS165.67-9.31 (-5.32%) ▼|MSFT484.52-13.78 (-2.77%) ▼|MU594.51-95.93 (-13.89%) ▼|NEE83.45-0.34 (-0.41%) ▼|NFLX56.73-1.73 (-2.96%) ▼|NKE32.92-1.41 (-4.11%) ▼|NOW87.61-1.26 (-1.42%) ▼|NVDA125.53-20.45 (-14.01%) ▼|ORCL101.19-9.38 (-8.48%) ▼|PEP140.54+1.54 (+1.11%) ▲|PFE27.40-0.14 (-0.51%) ▼|PG169.37+1.52 (+0.91%) ▲|PLTR143.49-10.19 (-6.63%) ▼|PM184.09-2.34 (-1.26%) ▼|QCOM149.94-12.07 (-7.45%) ▼|RTX190.17-2.54 (-1.32%) ▼|SBUX103.13-1.34 (-1.28%) ▼|SCHW90.16-1.96 (-2.13%) ▼|SO93.13-0.16 (-0.17%) ▼|SPG224.35-0.87 (-0.39%) ▼|T22.31+0.46 (+2.11%) ▲|TMO669.54-19.21 (-2.79%) ▼|TMUS165.60+3.07 (+1.89%) ▲|TSLA345.82-28.59 (-7.64%) ▼|TXN263.75-22.00 (-7.70%) ▼|UBER63.47-2.13 (-3.25%) ▼|UNH339.85+9.37 (+2.84%) ▲|UNP287.29-3.34 (-1.15%) ▼|UPS106.22-2.89 (-2.65%) ▼|USB56.05-1.21 (-2.11%) ▼|V401.87-0.38 (-0.09%) ▼|VZ46.48+0.74 (+1.62%) ▲|WFC78.62-1.99 (-2.47%) ▼|WMT127.95+1.91 (+1.52%) ▲|XOM159.99+1.06 (+0.67%) ▲|AAPL342.56-6.65 (-1.90%) ▼|ABBV286.20+2.66 (+0.94%) ▲|ABT103.00-0.87 (-0.84%) ▼|ACN221.17+2.59 (+1.18%) ▲|ADBE217.71-3.97 (-1.79%) ▼|AMAT302.63-36.30 (-10.71%) ▼|AMD424.39-64.80 (-13.25%) ▼|AMGN435.64-0.66 (-0.15%) ▼|AMT184.21+3.06 (+1.69%) ▲|AMZN246.82-10.55 (-4.10%) ▼|AVGO304.41-42.24 (-12.19%) ▼|AXP301.70-9.41 (-3.02%) ▼|BA155.89-4.62 (-2.88%) ▼|BAC47.04-1.53 (-3.15%) ▼|BKNG144.91-2.41 (-1.64%) ▼|BLK1,101.72-34.09 (-3.00%) ▼|BMY58.80+0.46 (+0.79%) ▲|BNY141.24-3.59 (-2.48%) ▼|BRK-B570.00-2.04 (-0.36%) ▼|C110.62-4.66 (-4.04%) ▼|CAT510.45-26.92 (-5.01%) ▼|CL98.71+1.83 (+1.89%) ▲|CMCSA24.90+0.04 (+0.16%) ▲|COF178.66-3.10 (-1.71%) ▼|COP136.12+1.13 (+0.84%) ▲|COST1,102.15+8.32 (+0.76%) ▲|CRM180.62-2.69 (-1.47%) ▼|CSCO90.64-4.06 (-4.29%) ▼|CVS80.84+0.80 (+1.00%) ▲|CVX208.37+1.87 (+0.91%) ▲|DE609.25-15.64 (-2.50%) ▼|DHR220.36-7.20 (-3.16%) ▼|DIS117.98-2.27 (-1.89%) ▼|DUK129.78+0.92 (+0.71%) ▲|EMR150.93-6.67 (-4.23%) ▼|FDX303.99-10.65 (-3.38%) ▼|GD341.50-5.84 (-1.68%) ▼|GE309.62-9.26 (-2.90%) ▼|GEV699.33-56.95 (-7.53%) ▼|GILD166.43-0.10 (-0.06%) ▼|GM78.71-3.04 (-3.72%) ▼|GOOG264.00-7.02 (-2.59%) ▼|GOOGL265.29-7.37 (-2.70%) ▼|GS790.69-56.84 (-6.71%) ▼|HD339.04+2.36 (+0.70%) ▲|HON212.64-5.20 (-2.39%) ▼|IBM224.44+0.56 (+0.25%) ▲|INTC51.28-4.44 (-7.97%) ▼|INTU270.44-39.58 (-12.77%) ▼|ISRG399.05-8.19 (-2.01%) ▼|JNJ270.47+3.33 (+1.25%) ▲|JPM310.53-9.69 (-3.03%) ▼|KO96.99+0.90 (+0.94%) ▲|LIN502.83-7.38 (-1.45%) ▼|LLY1,347.11-4.01 (-0.30%) ▼|LMT565.50-6.35 (-1.11%) ▼|LOW220.84+1.70 (+0.78%) ▲|LRCX183.27-20.41 (-10.02%) ▼|MA625.59-0.91 (-0.15%) ▼|MCD273.24+0.89 (+0.33%) ▲|MDLZ66.28+0.59 (+0.90%) ▲|MDT99.94-0.67 (-0.67%) ▼|META560.84-35.38 (-5.93%) ▼|MMM177.99-0.48 (-0.27%) ▼|MO74.87+0.19 (+0.25%) ▲|MRK133.72+0.91 (+0.69%) ▲|MS165.67-9.31 (-5.32%) ▼|MSFT484.52-13.78 (-2.77%) ▼|MU594.51-95.93 (-13.89%) ▼|NEE83.45-0.34 (-0.41%) ▼|NFLX56.73-1.73 (-2.96%) ▼|NKE32.92-1.41 (-4.11%) ▼|NOW87.61-1.26 (-1.42%) ▼|NVDA125.53-20.45 (-14.01%) ▼|ORCL101.19-9.38 (-8.48%) ▼|PEP140.54+1.54 (+1.11%) ▲|PFE27.40-0.14 (-0.51%) ▼|PG169.37+1.52 (+0.91%) ▲|PLTR143.49-10.19 (-6.63%) ▼|PM184.09-2.34 (-1.26%) ▼|QCOM149.94-12.07 (-7.45%) ▼|RTX190.17-2.54 (-1.32%) ▼|SBUX103.13-1.34 (-1.28%) ▼|SCHW90.16-1.96 (-2.13%) ▼|SO93.13-0.16 (-0.17%) ▼|SPG224.35-0.87 (-0.39%) ▼|T22.31+0.46 (+2.11%) ▲|TMO669.54-19.21 (-2.79%) ▼|TMUS165.60+3.07 (+1.89%) ▲|TSLA345.82-28.59 (-7.64%) ▼|TXN263.75-22.00 (-7.70%) ▼|UBER63.47-2.13 (-3.25%) ▼|UNH339.85+9.37 (+2.84%) ▲|UNP287.29-3.34 (-1.15%) ▼|UPS106.22-2.89 (-2.65%) ▼|USB56.05-1.21 (-2.11%) ▼|V401.87-0.38 (-0.09%) ▼|VZ46.48+0.74 (+1.62%) ▲|WFC78.62-1.99 (-2.47%) ▼|WMT127.95+1.91 (+1.52%) ▲|XOM159.99+1.06 (+0.67%) ▲|
13.1 C
New York
Sunday, November 22, 2026

Tag: Roche

Cancer Diagnostics Market to Reach US$ 41.5 Billion by 2031 at 7.2% CAGR, says Wissen Research

Sheridan, WY, Oct. 15, 2026 /PRNewswire/ -- The global cancer diagnostics market is valued at USD 29.3 billion in 2026 and is projected to reach...

Cancer Diagnostics Market to Reach US$ 41.5 Billion by 2031 at 7.2% CAGR, says Wissen Research

SHERIDAN, Wyo., Oct. 15, 2026 /PRNewswire/ -- The global cancer diagnostics market is valued at USD 29.3 billion in 2026 and is projected to reach...

Bioprocess Technology Market to Reach USD 134.06 Billion by 2035 – Credence Research

LONDON, Oct. 15, 2026 /PRNewswire/ -- The "Bioprocess Technology Market – Growth, Share, Opportunities & Competitive Analysis, 2025–2035" report has been added to the...

Neuroendocrine Prostate Cancer Market to Witness Growth at a 25% CAGR by 2036 Due to the Emergence of Emerging agents, including DLL3-targeted Therapies, ADCs,...

The neuroendocrine prostate cancer market is expected to grow steadily, driven by the rising recognition of NEPC as an aggressive and treatment-resistant form of...

Neuroendocrine Prostate Cancer Market to Witness Growth at a 25% CAGR by 2036 Due to the Emergence of Emerging agents, including DLL3-targeted Therapies, ADCs,...

The neuroendocrine prostate cancer market is expected to grow steadily, driven by the rising recognition of NEPC as an aggressive and treatment-resistant form of...

Rona Therapeutics enters into global license agreement with Roche for ALK7-targeting RNAi therapy for obesity and metabolic diseases

SANTA BARBARA, Calif., Oct. 13, 2026 /PRNewswire/ -- Rona Therapeutics today announced it has granted Roche (SIX: RO, ROG; OTCQX: RHHBY) an exclusive worldwide...

Rona Therapeutics enters into global license agreement with Roche for ALK7-targeting RNAi therapy for obesity and metabolic diseases

SANTA BARBARA, Calif., Oct. 13, 2026 /PRNewswire/ -- Rona Therapeutics today announced it has granted Roche (SIX: RO, ROG; OTCQX: RHHBY) an exclusive worldwide...

ArkBio Announces FDA Clearance to Initiate Phase II Trial of AK0406 for Influenza Prevention

SHANGHAI, Oct. 12, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the U.S. Food and Drug Administration (FDA) has granted...

ArkBio Announces FDA Clearance to Initiate Phase II Trial of AK0406 for Influenza Prevention

SHANGHAI, Oct. 13, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the U.S. Food and Drug Administration (FDA) has granted...

ArkBio Announces FDA Clearance to Initiate Phase II Trial of AK0406 for Influenza Prevention

SHANGHAI, Oct. 13, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the U.S. Food and Drug Administration (FDA) has granted...

Gen Announces Appointment of Talbott Roche to Board of Directors

TEMPE, Ariz. and PRAGUE , Oct. 9, 2026 /PRNewswire/ -- Gen Digital Inc. (NASDAQ: GEN), a global leader dedicated to powering Digital Freedom, today...

Innovent Announces Phase 3 RESTORE-3 Study of SYCUME® (Teprotumumab N01 Injection) Met Primary Endpoint in Inactive Thyroid Eye Disease

SYCUME® Significantly Improved Proptosis (Response Rate 60.4% / LS Mean Change from Baseline -1.88 mm) with Favorable Safety Profile in Participants with Inactive Thyroid...

Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRC

Roche Diagnostics has provided two molecular testing instruments to Institut National de Santé Publique (INSP) to support Ebola testing capacity in the DRC.Roche will...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRoche